Alli (Orlistat) leads to decrease of body weight in patients with obesity if taken systematically in combination with a low-calorie diet. The active component orlistat interferes in breakdown of food fats and reduces their absorption from the digestive tract. The effectiveness of orlistat depends on the amount of fats in the diet, so patients taking Alli should limit fat intake for a better result.
Alli is also known under the following brand-names: Xenical, Orlipastat, Orlipastatum, Orlistat.
*Alli is a trademark of GlaxoSmithKline